CN104524283A - Use of traditional Chinese medicine composition for preparing medicine for treating chronic gastritis - Google Patents
Use of traditional Chinese medicine composition for preparing medicine for treating chronic gastritis Download PDFInfo
- Publication number
- CN104524283A CN104524283A CN201410801533.XA CN201410801533A CN104524283A CN 104524283 A CN104524283 A CN 104524283A CN 201410801533 A CN201410801533 A CN 201410801533A CN 104524283 A CN104524283 A CN 104524283A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- rhizoma
- magnoliae officinalis
- cortex magnoliae
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 59
- 208000007882 Gastritis Diseases 0.000 title claims abstract description 35
- 208000023652 chronic gastritis Diseases 0.000 title claims abstract description 31
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 238000011282 treatment Methods 0.000 claims abstract description 30
- 210000000582 semen Anatomy 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims description 25
- 238000009835 boiling Methods 0.000 claims description 20
- 241000244155 Taenia Species 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 14
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 6
- 238000005202 decontamination Methods 0.000 claims description 5
- 230000003588 decontaminative effect Effects 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 abstract description 21
- 208000011580 syndromic disease Diseases 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 14
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000004069 differentiation Effects 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- 241001529821 Agastache Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000010254 Jasminum officinale Nutrition 0.000 abstract 1
- 240000005385 Jasminum sambac Species 0.000 abstract 1
- 241000218378 Magnolia Species 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 241001162994 Rugosus Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 description 23
- 208000002193 Pain Diseases 0.000 description 18
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 229940079593 drug Drugs 0.000 description 14
- 206010047700 Vomiting Diseases 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 12
- 230000008673 vomiting Effects 0.000 description 10
- 210000001367 artery Anatomy 0.000 description 8
- 210000001156 gastric mucosa Anatomy 0.000 description 8
- 210000003462 vein Anatomy 0.000 description 8
- 206010000087 Abdominal pain upper Diseases 0.000 description 7
- 230000001154 acute effect Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 208000037921 secondary disease Diseases 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010014080 Ecchymosis Diseases 0.000 description 2
- 206010053155 Epigastric discomfort Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 208000006766 bile reflux Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 210000001809 melena Anatomy 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 210000004203 pyloric antrum Anatomy 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Botany (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicines and particularly relates to use of a traditional Chinese medicine composition for preparing a medicine for treating chronic gastritis. The traditional Chinese medicine composition treating chronic gastritis is prepared from the following raw materials: rhizoma anemarrhenae, pinellia ternate, jasmine, rhizoma phragmitis, mangnolia officinalis, magnolia obavata, semen raphani, caulis bambusae in taeniam, agastache rugosus, scutellaria baicalensis, pericarpium citri reticulatae and liquorice. The traditional Chinese medicine composition for treating chronic gastritis gives play to an effect of syndrome differentiation and treatment of traditional Chinese medicines, is appropriate to medicate, has a relatively good treatment effect on various chronic gastritis, can be used for quickly and effectively relieving symptoms of chronic gastritis and meanwhile has the advantages of treating both symptoms and root causes and being short in treatment course and difficult to relapse.
Description
Technical field
The invention belongs to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine composition for the preparation of the purposes in treatment chronic gastritis medicine.
Background technology
Gastritis is a kind of digestive system commonly encountered diseases, frequently-occurring disease, is the general designation of the stomach lining inflammation caused by a variety of causes, can be divided into acute and chronic two classes.Acute chronic gastritis is divided into pure and erosive, and main manifestations is epigastric discomfort, pain, anorexia, Nausea and vomiting, hematemesis and melena; Chronic gastritis is divided into shallow, atrophic and hypertrophica, and main manifestations is glutted, pantothenic acid, belch and irregularities stomachache after meal, and the course of disease is long, recurrent exerbation.Chronic gastritis is the gastric mucosa chronic inflammation pathological changes caused by many reasons, and sickness rate increases with the age and increases, full China's majority of cases is the gastritis based on gastric antrum, the later stage is main pathological characteristic with gastric mucosa intrinsic body of gland atrophy and enteraden epithelial metaplasia.About half has middle epigastric discomfort, glutted, dull pain, burning pain, without obvious rhythmicity, heavier after general feed; Secondly, inappetence, belch, acid regurgitation, the indigestion symptom such as to feel sick are also more common.
Chinese medicine has treating both the principal and secondary aspects of a disease, the advantage not easily recurred in treatment chronic gastritis.The traditional Chinese medical science thinks this sick the disease being located in the spleen stomach, and Deficiency and coldness of spleen and stomach, makes the clear YANG failing to ascend of spleen, the turbid YIN failing to descend of stomach, and stomach receiving food and drink, digesting food, main logical effect of falling is not normal thus cause dyspepsia, excessiveness of stomach-fire.Soothing liver and strengthening spleen is worked as in medication and middle clearing stomach is this, and food stagnation removingization is stagnant, relieving restlessness pathogenic fire purging is mark, and treating both the principal and secondary aspects of a disease can be fully recovered.
The medicine of current treatment chronic gastritis has a lot, but its curative effect letter is waited to improve, and compatibility of drugs is simplified not.Therefore in the urgent need to developing a kind of evident in efficacy, economical and practical, taste is moderate, toxic and side effects is low Chinese medicine with better for patient service.
Summary of the invention
In order to increase available types of drugs to vast Patients with Chronic Gastritis, and reach the effect for the treatment of both the principal and secondary aspects of a disease.The invention provides a kind of Chinese medicine composition for the preparation of the purposes in treatment chronic gastritis medicine.
The present invention is achieved through the following technical solutions:
Chinese medicine composition is for the preparation of the purposes in treatment chronic gastritis medicine, and described Chinese medicine composition is prepared from by following raw material: the Rhizoma Anemarrhenae, the Rhizoma Pinelliae, Fructus Gardeniae, Rhizoma Phragmitis, Cortex Magnoliae Officinalis, Cortex Magnoliae Officinalis, Semen Raphani, Caulis Bambusae In Taenia, Herba Pogostemonis, Radix Scutellariae, Pericarpium Citri Reticulatae, Radix Glycyrrhizae.
Preferably, the Chinese medicine composition for the treatment of chronic gastritis provided by the present invention, be made up of the raw material of following weight portion:
Rhizoma Anemarrhenae 13-21 Rhizoma Pinelliae 7-17 Fructus Gardeniae 7-17 Rhizoma Phragmitis 5-13
Cortex Magnoliae Officinalis 3-13 Cortex Magnoliae Officinalis 3-13 Semen Raphani 3-11 Caulis Bambusae In Taenia 3-11
Herba Pogostemonis 5-9 Radix Scutellariae 1-7 Pericarpium Citri Reticulatae 1-7 Radix Glycyrrhizae 1-7
As one of preferred version of the present invention, the weight proportion that the present invention treats the Chinese medicine composition each component of chronic gastritis is:
The Rhizoma Anemarrhenae 18 Rhizoma Pinelliae 16 Fructus Gardeniae 10 Rhizoma Phragmitis 10
Cortex Magnoliae Officinalis 8 Cortex Magnoliae Officinalis 8 Semen Raphani 8 Caulis Bambusae In Taenia 6
Herba Pogostemonis 6 Radix Scutellariae 4 Pericarpium Citri Reticulatae 2 Radix Glycyrrhizae 4
As preferred version two of the present invention, the weight proportion that the present invention treats the Chinese medicine composition each component of chronic gastritis is:
The Rhizoma Anemarrhenae 20 Rhizoma Pinelliae 14 Fructus Gardeniae 12 Rhizoma Phragmitis 8
Cortex Magnoliae Officinalis 6 Cortex Magnoliae Officinalis 10 Semen Raphani 6 Caulis Bambusae In Taenia 6
Herba Pogostemonis 8 Radix Scutellariae 6 Pericarpium Citri Reticulatae 2 Radix Glycyrrhizae 2
Use for convenience of patient, another object of the present invention is to provide a kind of preparation method for the treatment of the Chinese medicine composition of chronic gastritis, specifically comprise the following steps:
(1) by the Rhizoma Anemarrhenae, Cortex Magnoliae Officinalis, Semen Raphani, Herba Pogostemonis, Radix Scutellariae, Pericarpium Citri Reticulatae, Radix Glycyrrhizae decontamination, clean, dry, grind to form 100-200 order fine powder;
(2) Rhizoma Phragmitis is mashed, get its juice, for subsequent use;
(3) by the Rhizoma Pinelliae, Fructus Gardeniae, Cortex Magnoliae Officinalis, Caulis Bambusae In Taenia, clean, oven dry, coarse powder is ground into;
(4) by coarse powder prepared by step (3), add 4-8 times amount water soaking 1-3 hour, intense fire decocts boiling 30 minutes, then uses slow fire boiling 1-3 hour; Filter, filtering residue adds 2-4 times of water gaging, and intense fire decocts boiling 15 minutes, then uses slow fire boiling 1-2 hour; Filter, merge twice filtrate, it is the dope of 1.10-1.20 that filtrate is concentrated into relative density under 60 DEG C of environment, for subsequent use;
(5) dope that juice above-mentioned steps (2) prepared and step (4) are made merges, and is concentrated into the thick paste that relative density is 1.20-1.35, drying under reduced pressure, crosses 100-200 mesh sieve, obtain uniform fine powder after pulverizing;
(6) incapsulate shell after fine powder mix homogeneously step (1) and step (5) made and make capsule, or add corresponding adjuvant and make pill, granule or tablet.
Effect of each Chinese medicine component in the present invention:
The Rhizoma Anemarrhenae: clearing up internal heat by using drugs of bitter in taste and cold in nature, can clearing stomach fire, and nourishing and moistening ZANG FU-organ with drugs sweet in taste and cold in nature, again can nourishing stomach-YIN, promoting the production of body fluid to quench thirst, contains or the scorching person of the deficiency of YIN all can select in stomach-fire.
The Rhizoma Pinelliae: normalizing the stomach by guiding QI downward is preventing or arresting vomiting key medicine, for gastropyretic vomiting, and gastrofrigid vomiting, vomiting with yin asthenia, syndrome of adverse flow of QI caused by deficiency of the stomach.
Fructus Gardeniae: be good at through pathogenic heat with clear removing pathogen in the heart, liver, stomach, can control accumulated heat burning pain in the epigastrium in stomach.
Rhizoma Phragmitis: rush down gastric heat clearly, stomach function regulating preventing or arresting vomiting, for the thirsty polydipsia of gastric heat impairment of body fluid, the vomiting of adverse rising of stomach-heat.Mash extracting juice
Cortex Magnoliae Officinalis: bitter dry pungent row, can dampness, again can circulation of qi promoting, for therapeutic method to keep the adverse QI flowing downwards alleviating distention in middle-JIAO, and relieving distension by promoting circulation of QI.
Cortex Magnoliae Officinalis: there is circulation of qi promoting removing food stagnancy, dampness is except full, and sending down the abnormal ascending QI first is breathed heavily; For eating accumulation, abdominal distention constipation, fullness in the chest is breathed with cough.
Semen Raphani: promoting digestion and invigorating the stomach, circulation of qi promoting dissipating blood stasis, for controlling distension and fullness in the abdomen caused by stagnation of QI due to dyspepsia or pain, dysentery is suffered from abdominal pain.
Caulis Bambusae In Taenia: sweet cold profit, kind Qinghua heat-phlegm, for controlling the key medicine of gastric heat vomiting.
Herba Pogostemonis: acrid in the mouth can be manageed it, returns spleen, stomach, lung meridian, has removing dampness, expelling summer-heat, the effect of stomach function regulating preventing or arresting vomiting, and for fever with aversion to cold, headache gastral cavity is vexed, and vomiting and nausea is vomited and diarrhoea.
Radix Scutellariae: clearing away heat-fire, dampness is detoxified, and enters lung Liver Channel, and for cough due to lung-heat, calentura unconsciousness due to high fever, liver-fire is had a headache.
Pericarpium Citri Reticulatae: row QI of the spleen and stomach, action temperature and, stopping nausea and vomiting by lowering the adverse flow of QI, drying damp and strengthening spleen, for stagnation of QI in spleen and stomach, gastral cavity abdomen goes up painful.
Radix Glycyrrhizae: be in harmonious proportion the property of medicine, by removing toxic substances, can the toxicity of some medicine in the side of reduction, by relieving spasm to stop pain, can some medicine stimulating gastrointestinal causes in the side of alleviation stomachache, its sweet taste is strong, the flavour of rectifiable side's Chinese medicine.
In above-mentioned all medicines, the Rhizoma Anemarrhenae is monarch drug, the property of its bitter cold, can clearing stomach fire, and its property is sweet again, again can nourishing stomach-YIN, plays primary treatment effect to acute and chronic gastritis; The Rhizoma Pinelliae, Fructus Gardeniae, Rhizoma Phragmitis are ministerial drug, and wherein, Fructus Gardeniae can rush down clearly the pathogenic heat of stomach warp, can strengthen treating primary symptom, and the Rhizoma Pinelliae and Rhizoma Phragmitis are preventing or arresting vomiting good medicine, and monarch drug can be assisted to strengthen the double disease for the treatment of; Cortex Magnoliae Officinalis, Cortex Magnoliae Officinalis, Semen Raphani, Radix Scutellariae, Herba Pogostemonis, Caulis Bambusae In Taenia, Pericarpium Citri Reticulatae are adjuvant drug, and with soothing liver and strengthening spleen and middle clearing stomach for effecting a permanent cure, relieving restlessness pathogenic fire purging stagnant with food stagnation removingization is for taking stopgap measures; Radix Glycyrrhizae, for making medicine, is coordinating the actions of various ingredients in a prescription drug effect, corrects prescription flavour.Prescription follows monarch, minister, the square gauge processed rule of helping, making, and medication is suitable for, and compatibility is simplified, and makes a distinction between the important and the lesser one, treating both the principal and secondary aspects of a disease.
Compared to the prior art the present invention, has following technique effect:
1, the present invention treats the Chinese medicine composition of chronic gastritis, plays the effect of Chinese medicine Coryza Treated by Syndrome Differentiation, and medication is suitable for, good therapeutical effect is all had to various types of chronic gastritis, can the symptom of fast and effeciently relieve chronic gastritis, there is treating both the principal and secondary aspects of a disease simultaneously, short treating period, the advantage not easily recurred.
2, the present invention treats the Chinese medicine composition of chronic gastritis, and medication is simplified, and dosage is few, and without toxic raw materials, taste is moderate, and the property of medicine is gentle, has the merit of nourishing spleen and stomach, is applicable to long-term taking.
3, the present invention treats the Chinese medicine composition of chronic gastritis, can be prepared into oral formulations, such as capsule, pill, granule or other dosage form, and mouthfeel is good, avoids the inconvenience that decocting for Chinese herbal medicine and use thereof bring.
4, the present invention treats the Chinese medicine composition of chronic gastritis, and preparation is simple, is applicable to suitability for industrialized production.
detailed description of the invention:
Below by way of the description of detailed description of the invention, the invention will be further described, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, various amendment or improvement can be made, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.
the preparation of embodiment 1 capsule
Preparation method is as follows:
(1) take Rhizoma Anemarrhenae 18kg, Cortex Magnoliae Officinalis 8 kg, Semen Raphani 8 kg, Herba Pogostemonis 6 kg, Radix Scutellariae 4 kg, Pericarpium Citri Reticulatae 2 kg, Radix Glycyrrhizae 4 kg decontamination, clean, dry, grind to form 200 order fine powders;
(2) Rhizoma Phragmitis is mashed, prepare juice 10 kg, for subsequent use;
(3) Rhizoma Pinelliae 16 kg, Fructus Gardeniae 10 kg, Cortex Magnoliae Officinalis 8 kg, Caulis Bambusae In Taenia 6 kg are cleaned, dry, be ground into coarse powder;
(4) by coarse powder prepared by step (3), add 6 times amount water soaking 2 hours, intense fire decocts boiling 30 minutes, then uses slow fire boiling 2 hours; Filter, filtering residue adds 2 times of water gagings, and intense fire decocts boiling 15 minutes, then uses slow fire boiling 1 hour; Filter, merge twice filtrate, it is the dope of 1.10-1.20 that filtrate is concentrated into relative density under 60 DEG C of environment, for subsequent use;
(5) dope that juice above-mentioned steps (2) prepared and step (4) are made merges, and is concentrated into the thick paste that relative density is 1.20-1.35, drying under reduced pressure, crosses 200 mesh sieves, obtain uniform fine powder after pulverizing;
(6) incapsulate shell after fine powder mix homogeneously step (1) and step (5) made and make capsule.
the preparation of embodiment 2 capsule
The preparation method of capsule is as follows:
(1) take the Rhizoma Anemarrhenae 20 kg, Cortex Magnoliae Officinalis 10 kg, Semen Raphani 6 kg, Herba Pogostemonis 8 kg, Radix Scutellariae 6 kg, Pericarpium Citri Reticulatae 2 kg, Radix Glycyrrhizae 2 kg decontamination, clean, dry, grind to form 200 order fine powders;
(2) Rhizoma Phragmitis is mashed, prepare juice 8 kg, for subsequent use;
(3) Rhizoma Pinelliae 14 kg, Fructus Gardeniae 12 kg, Cortex Magnoliae Officinalis 6 kg, Caulis Bambusae In Taenia 6 kg are cleaned, dry, be ground into coarse powder;
(4) by coarse powder prepared by step (3), add 5 times amount water soaking 3 hours, intense fire decocts boiling 30 minutes, then uses slow fire boiling 2 hours; Filter, filtering residue adds 3 times of water gagings, and intense fire decocts boiling 15 minutes, then uses slow fire boiling 2 hours; Filter, merge twice filtrate, it is the dope of 1.10-1.20 that filtrate is concentrated into relative density under 60 DEG C of environment, for subsequent use;
(5) dope that juice above-mentioned steps (2) prepared and step (4) are made merges, and is concentrated into the thick paste that relative density is 1.20-1.35, drying under reduced pressure, crosses 200 mesh sieves, obtain uniform fine powder after pulverizing;
(6) incapsulate shell after fine powder mix homogeneously step (1) and step (5) made and make capsule.
the preparation of embodiment 3 pill
Preparation method is as follows:
(1) take the Rhizoma Anemarrhenae 20 kg, Cortex Magnoliae Officinalis 12 kg, Semen Raphani 4 kg, Herba Pogostemonis 8 kg, Radix Scutellariae 2 kg, Pericarpium Citri Reticulatae 2 kg, Radix Glycyrrhizae 2 kg decontamination, clean, dry, grind to form 100 order fine powders;
(2) Rhizoma Phragmitis is mashed, prepare juice 8 kg, for subsequent use;
(3) Rhizoma Pinelliae 14 kg, Fructus Gardeniae 12 kg, Cortex Magnoliae Officinalis 10kg, Caulis Bambusae In Taenia 6 kg are cleaned, dry, be ground into coarse powder;
(4) by coarse powder prepared by step (3), add 8 times amount water soaking 2 hours, intense fire decocts boiling 30 minutes, then uses slow fire boiling 2 hours; Filter, filtering residue adds 2 times of water gagings, and intense fire decocts boiling 15 minutes, then uses slow fire boiling 1 hour; Filter, merge twice filtrate, it is the dope of 1.10-1.20 that filtrate is concentrated into relative density under 60 DEG C of environment, for subsequent use;
(5) dope that juice above-mentioned steps (2) prepared and step (4) are made merges, and is concentrated into the thick paste that relative density is 1.20-1.35, drying under reduced pressure, crosses 100 mesh sieves, obtain uniform fine powder after pulverizing;
(6) add Mel after fine powder mix homogeneously step (1) and step (5) made to stir in right amount, send into pellet processing machine, make honeyed pill.
clinical data
chinese medicine of the present inventioncompositions
the clinical observation for the treatment of chronic gastritis:
1 physical data
The present invention has carried out clinical comparison medication to the 210 routine acute and chronic gastritis sufferers accepted for medical treatment year April in June, 2012 to 2014 and has observed, wherein male 129 example, women 81 example, patient age 22 to 75 years old, the course of disease 3 months-8 years is random is divided into treatment group and matched group (each 105 is routine) by patient, the physical data no significant difference of two groups of patients (
p> 0.05).
, tcm diagnosis standard:
(the diagnosis tentative standard that in November, 1989, CAIM's digestive system disease Professional Committee formulated)
1)
incoordination between the liver and stomachtype: mainly want syndrome: 1. epigastric distending pain or pain string two side of body.2. belch is frequent.3. noisy pantothenic acid.Secondary syndrome: the 1. acute Active inflammation of gastric mucosa.2. bile reflux.Tongue
resemblepulse condition: body of the tongue is light red, white and thin fur or thick in vain; Stringy pulse.Pattern of syndrome is determined: 1. possess primary symptom two, tongue pulse condition meets substantially.2. possess primary symptom 1 and time disease 1, tongue pulse condition meets substantially.Possess any 1 person can determine.
2) weakness of the spleen and stomach (comprising deficiency and coldness) type: main syndromes: 1. vague epigastralgia.2. pain relieved by pressing happiness of having a stomachache is warm.3. feeling of distension and oppression feeling of fullness after food.4. appetite stimulator.5. loose stool
diarrhoea.6. weak extremity are aching and limp.Secondary syndrome: 1. gastric mucosa is red and white with Bai Weizhu.2. mucus is thin and many.3. gastric acid is on the low side.Picture of the tongue pulse condition: 1. body of the tongue is light red, white and thin fur or white, has indentation.2. deep-thready pulse.Pattern of syndrome is determined: 1. possess main symptom 3, tongue arteries and veins meets substantially.2. possess primary symptom two and time disease 1, tongue arteries and veins meets substantially.Possess any 1 can determine.
3)
damp-heat in the spleen and stomachtype: main syndromes: the 1. scorching hot distending pain of gastral cavilty.2. bitter taste halitosis.3. yellowish urine.4. gastral cavity abdomen painful abdominal mass is vexed, thirst but no desire to drink.Secondary syndrome: gastric mucosa is acute, Active inflammation, congested rotten to the corn obviously.Picture of the tongue pulse condition: red tongue, limit point is dark red, and yellow fur is thick or greasy.Rolling pulse, tense pulse.Pattern of syndrome is determined: 1. possess primary symptom two, tongue arteries and veins meets substantially.2. possess primary symptom 1 and secondary disease, tongue arteries and veins meets substantially.Possess any 1 can determine.
4) type of deficiency of stomach yin: main syndromes: the 1. scorching hot pain of gastral cavilty.2. dry mouth and tougue.3. be hard and dry.Secondary syndrome: 1. gastric mucosa lamellar is red and white, and mucosa is thinning.2. gastric mucosa is dry, and mucus is few.3. gastric acid is on the low side.Picture of the tongue pulse condition: 1. red tongue with a little fluid or have crackle.2. thready pulse or stringy and thready pulse.Pattern of syndrome is determined: 1. possess primary symptom two and tongue arteries and veins meets.2. possess primary symptom 1 and secondary disease two, tongue arteries and veins meets substantially.Possess above any 1 can determine.
5) stomach network blood stasis type: main disease: 1. gastral cavilty localized pain, not pain relieved by pressing.2. have a stomach-ache and with the passing of time do not heal.3. ambassador's occult blood positive or black hemafecia.Secondary disease: the congested swelling of gastric mucosa, companion's ecchymosis or petechia.Picture of the tongue pulse condition: 1. dimly red tongue, or purple dark, or have ecchymosis.2. stringy and hesitant pulse.Pattern of syndrome is determined: 1. possess primary symptom two, tongue arteries and veins meets substantially.2. possess primary symptom 1 and add time disease; Tongue arteries and veins meets substantially.Possess above any 1 can determine.
, Therapeutic Method
Treatment group: take capsule prepared by the embodiment of the present invention 1, each 2, every day 3 times, one after each meal.7 days courses for the treatment of, serve on 3 courses for the treatment of.
Matched group: take SANJIU WEITAI KELI, one time 1 bag, 2 times on the one, 15 days courses for the treatment of, serve on 3 courses for the treatment of.
, efficacy assessment standard
Recovery from illness: patient clinical symptom disappears completely, stomach is without pain, and appetite is recovered.
Effective: patient clinical symptom has remarkable alleviation, stomach pain symptom obviously alleviates, and attack times obviously reduces.
Effective: patient clinical symptom is alleviated to some extent, stomach pain symptom alleviates to some extent, and attack times reduces to some extent.
Invalid: patient clinical symptom is without any improvement.
Total effective rate=cure rate+obvious effective rate+effective percentage
5, statistical method
This is organized all statistical datas and all adopts SPSS17.0 software to carry out analyzing and processing, with
p< 0.05 has statistical significance for difference.
, therapeutic outcome
Two groups of patient clinical curative effects, see table 1
A table 1 liang group patient clinical curative effect situation compares
As can be seen from Table 1, after the treatment of 3 courses for the treatment of, treatment by Chinese herbs group of the present invention, cure rate is up to 72.4%, and matched group cure rate is only 38.1%.The total effective rate for the treatment of group and matched group is respectively 97.1% and 78.1%, visible, and treatment group cure rate and total effective rate are obviously better than matched group.Through statistical procedures, between two groups of patient clinical curative effects difference have statistical significance (
p< 0.05).
Two groups of patient pain alleviate situation, see table 2
A table 2 liang group patient pain is alleviated situation and is compared
| Group | Number of cases | One weekend (rate) | Two weekends (rate) | Four weekends (rate) |
| Treatment group | 105 | 50（47.6） | 75（71.4） | 102（97.1） |
| Matched group | 105 | 35（33.3） | 50（47.6） | 82（78.1） |
As can be seen from Table 2, treatment group 1 weekend, 2 weekends, 4 weekend pain disappearance rate be respectively 47.6%, 71.4%, 97.1%, corresponding matched group is respectively 33.3%, 47.6%, 78.1%.No matter visible be 1 weekend, 2 weekends or the pain relief situation at 4 weekends, and treatment group is all better than matched group.
Conclusion: the present invention all has good therapeutical effect to chronic gastritis, is better than SANJIU WEITAI KELI.
Claims (5)
1. Chinese medicine composition is for the preparation of the purposes in treatment chronic gastritis medicine, and it is characterized in that, described Chinese medicine composition is prepared from by following raw material:
The Rhizoma Anemarrhenae, the Rhizoma Pinelliae, Fructus Gardeniae, Rhizoma Phragmitis, Cortex Magnoliae Officinalis, Cortex Magnoliae Officinalis, Semen Raphani, Caulis Bambusae In Taenia, Herba Pogostemonis, Radix Scutellariae, Pericarpium Citri Reticulatae, Radix Glycyrrhizae.
2. purposes according to claim 1, is characterized in that, described Chinese medicine composition is prepared from by the raw material of following weight portion:
Rhizoma Anemarrhenae 13-21 Rhizoma Pinelliae 7-17 Fructus Gardeniae 7-17 Rhizoma Phragmitis 5-13
Cortex Magnoliae Officinalis 3-13 Cortex Magnoliae Officinalis 3-13 Semen Raphani 3-11 Caulis Bambusae In Taenia 3-11
Herba Pogostemonis 5-9 Radix Scutellariae 1-7 Pericarpium Citri Reticulatae 1-7 Radix Glycyrrhizae 1-7.
3. purposes according to claim 1, is characterized in that, described Chinese medicine composition is prepared from by the raw material of following weight portion:
The Rhizoma Anemarrhenae 18 Rhizoma Pinelliae 16 Fructus Gardeniae 10 Rhizoma Phragmitis 10
Cortex Magnoliae Officinalis 8 Cortex Magnoliae Officinalis 8 Semen Raphani 8 Caulis Bambusae In Taenia 6
Herba Pogostemonis 6 Radix Scutellariae 4 Pericarpium Citri Reticulatae 2 Radix Glycyrrhizae 4.
4. purposes according to claim 1, is characterized in that, described Chinese medicine composition is prepared from by the raw material of following weight portion:
The Rhizoma Anemarrhenae 20 Rhizoma Pinelliae 14 Fructus Gardeniae 12 Rhizoma Phragmitis 8
Cortex Magnoliae Officinalis 6 Cortex Magnoliae Officinalis 10 Semen Raphani 6 Caulis Bambusae In Taenia 6
Herba Pogostemonis 8 Radix Scutellariae 6 Pericarpium Citri Reticulatae 2 Radix Glycyrrhizae 2.
5. purposes according to claim 1, is characterized in that, the preparation method of described Chinese medicine composition, comprises the following steps:
(1) by the Rhizoma Anemarrhenae, Cortex Magnoliae Officinalis, Semen Raphani, Herba Pogostemonis, Radix Scutellariae, Pericarpium Citri Reticulatae, Radix Glycyrrhizae decontamination, clean, dry, grind to form 100-200 order fine powder;
(2) Rhizoma Phragmitis is mashed, get its juice, for subsequent use;
(3) by the Rhizoma Pinelliae, Fructus Gardeniae, Cortex Magnoliae Officinalis, Caulis Bambusae In Taenia, clean, oven dry, coarse powder is ground into;
(4) by coarse powder prepared by step (3), add 4-8 times amount water soaking 1-3 hour, intense fire decocts boiling 30 minutes, then uses slow fire boiling 1-3 hour; Filter, filtering residue adds 2-4 times of water gaging, and intense fire decocts boiling 15 minutes, then uses slow fire boiling 1-2 hour; Filter, merge twice filtrate, it is the dope of 1.10-1.20 that filtrate is concentrated into relative density under 60 DEG C of environment, for subsequent use;
(5) dope that juice above-mentioned steps (2) prepared and step (4) are made merges, and is concentrated into the thick paste that relative density is 1.20-1.35, drying under reduced pressure, crosses 100-200 mesh sieve, obtain uniform fine powder after pulverizing;
(6) incapsulate shell after fine powder mix homogeneously step (1) and step (5) made and make capsule, or add corresponding adjuvant and make pill, granule or tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410801533.XA CN104524283A (en) | 2014-12-22 | 2014-12-22 | Use of traditional Chinese medicine composition for preparing medicine for treating chronic gastritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410801533.XA CN104524283A (en) | 2014-12-22 | 2014-12-22 | Use of traditional Chinese medicine composition for preparing medicine for treating chronic gastritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104524283A true CN104524283A (en) | 2015-04-22 |
Family
ID=52840039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410801533.XA Pending CN104524283A (en) | 2014-12-22 | 2014-12-22 | Use of traditional Chinese medicine composition for preparing medicine for treating chronic gastritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104524283A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105169212A (en) * | 2015-10-30 | 2015-12-23 | 江崇礼 | Traditional Chinese medicine composition for treating chronic gastritis |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101411832A (en) * | 2008-12-01 | 2009-04-22 | 晁峰峰 | Medicament for treating chronic gastritis |
| CN101757575A (en) * | 2008-12-24 | 2010-06-30 | 天津市中宝制药有限公司 | Chinese medicine composition for treating incoordination between spleen and stomach |
| CN101757576A (en) * | 2008-10-27 | 2010-06-30 | 薛立英 | Traditional Chinese medicine preparation |
| CN103055236A (en) * | 2012-12-23 | 2013-04-24 | 徐化利 | Traditional Chinese medicine formula for treating epiagstric pain |
-
2014
- 2014-12-22 CN CN201410801533.XA patent/CN104524283A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101757576A (en) * | 2008-10-27 | 2010-06-30 | 薛立英 | Traditional Chinese medicine preparation |
| CN101411832A (en) * | 2008-12-01 | 2009-04-22 | 晁峰峰 | Medicament for treating chronic gastritis |
| CN101757575A (en) * | 2008-12-24 | 2010-06-30 | 天津市中宝制药有限公司 | Chinese medicine composition for treating incoordination between spleen and stomach |
| CN103055236A (en) * | 2012-12-23 | 2013-04-24 | 徐化利 | Traditional Chinese medicine formula for treating epiagstric pain |
Non-Patent Citations (4)
| Title |
|---|
| 张庆鹏: "半夏泻心汤治疗慢性胃炎96例", 《实用中医药杂志》 * |
| 徐重明: "慢性脾胃病的辨证论治", 《河北中医》 * |
| 李晓月: "自拟清胃化湿汤治疗慢性浅表性胃炎64例", 《中国乡村医药杂志》 * |
| 赵建民: "孟繁华治疗阴虚型胃病经验举隅", 《山西中医》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105169212A (en) * | 2015-10-30 | 2015-12-23 | 江崇礼 | Traditional Chinese medicine composition for treating chronic gastritis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105169212A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN104940784A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN107095995B (en) | A pharmaceutical composition for treating gastritis and gastric ulcer, and its preparation method | |
| CN102805843A (en) | Drug for curing stomachache and preparation method thereof | |
| CN103055257B (en) | Traditional Chinese medicine for treating chronic gastritis and preparation method thereof | |
| CN108653432B (en) | Traditional Chinese medicine composition and preparation thereof | |
| CN103212026B (en) | A kind of Chinese medicine for the treatment of cholelithiasis and preparation method thereof and instructions of taking | |
| CN104524283A (en) | Use of traditional Chinese medicine composition for preparing medicine for treating chronic gastritis | |
| CN102670889A (en) | Chinese medicine for treating chronic gastritis | |
| CN103212032B (en) | Traditional Chinese medicine composition for treating gastric diseases | |
| CN105381291A (en) | Traditional Chinese medicine composition for preventing and treating pneumonia, preparation method and applications thereof | |
| CN104547356A (en) | Traditional Chinese medicine composition for treating heat evil attacking stomach type chronic gastritis | |
| CN104667252A (en) | Traditional Chinese medicine for treating acute gastroenteritis | |
| CN104189435B (en) | Traditional Chinese medicine for treating phlegm-heat stasis-type globus hysteriocus | |
| CN102772645B (en) | Traditional Chinese medicine for treating cold and preparation method thereof | |
| CN114404549B (en) | Traditional Chinese medicine composition for treating chronic atrophic gastritis and preparation method thereof | |
| CN103656199B (en) | A kind of Chinese medicine for the treatment of deficiency of kidney yin syndrome cough | |
| CN102641445A (en) | Medicine for treating dysentery and preparing method thereof | |
| CN104491542A (en) | Traditional Chinese medicine for treating chronic gastritis | |
| CN105168709A (en) | Traditional Chinese medicine composition for treating stomach distension | |
| CN105435202A (en) | Medicinal preparation for treating gastritis and purpose thereof | |
| CN105106405A (en) | Traditional Chinese medicine for treating allergic eczema | |
| CN104147199B (en) | One is used for the treatment of uremic Chinese medicine | |
| CN104225107B (en) | Traditional Chinese medicine for treating liver Qi stagnation type globus hysteriocus | |
| CN104352691A (en) | Traditional Chinese medicine decoction for treating bronchial asthma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150422 |